Selway Capital Acquisition Corp. 4
4 · Selway Capital Acquisition Corp. · Filed Aug 30, 2013
Insider Transaction Report
Form 4
DURKIN THOMAS E III
Director
Transactions
- Other
Series C Common Stock
2013-06-28−150,000→ 13,000 total(indirect: By Durkin & Durkin LLP)
Footnotes (2)
- [F1]On June 28, 2013, the Reporting Person entered into a rescission agreement with the Issuer for the cancellation of an aggregate of 150,000 shares of common stock issued to the Reporting Person on April 10, 2013.
- [F2]The Reporting Person has voting and investment control over, and a pecuniary interest in, the 13,000 shares held by Durkin & Durkin LLP, of which 1,300 shares are subject to a share escrow agreement dated April 10, 2013 (the "Closing Payment Escrow Agreement"). Such shares will be held in escrow and subject to cancellation until April 10, 2014 to cover certain indemnification obligations made by Healthcare Corporation of America ("HCCA") to the Issuer pursuant to an Agreement and Plan of Merger dated January 25, 2013, by and among the Issuer, Selway Merger Sub Inc., HCCA, Prescription Corporation of America, a wholly owned subsidiary of HCCA, Gary Sekulski, as the representative of the stockholders of HCCA, and Edmundo Gonzalez, as the Issuer's representative.